Author

B. Ateeq

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 9

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 8 Approach:experimental assay· 7 Assay:bulk RNA-seq· 6 Research Focus:gene regulatory network inference· 5 Research Focus:cancer & tumor microenvironment· 4 Approach:statistical model· 4 Research Focus:cell type annotation· 3 Research Focus:differential expression· 2

Frequent Co-Authors

N. Palanisamy· 5 shared S. Carskadon· 5 shared N. Gupta· 4 shared A. Goel· 3 shared A. Yadav· 3 shared N. Manzar· 3 shared V. Bhatia· 3 shared A. Bajpai· 2 shared

Activity by Year

2018-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

5 shared papersCancer Biology

N. Palanisamy

Mutual co-authors in cluster

Author profile →

9 papers

Recent·Most cited

An integrative proteomics approach identifies tyrosine kinase KIT as a novel therapeutic target for SPINK1-positive prostate cancer.

N. Manzar, U. K. Khan, A. Goel, S. Carskadon, N. Gupta, N. Palanisamy, B. Ateeq

The paper identifies KIT as a therapeutic target for SPINK1-positive prostate cancer through integrative proteomics and shows KIT inhibition reduces tumor growth and metastasis.

bioRxiv · Jul 24, 2023Cancer Biology

Transcriptional regulation of Dyskerin via canonical WNT signaling modulates sphingolipid biosynthesis and drives colorectal cancer.

S. Nigam, U. K. Khan, A. Praveen, A. Shendre, S. Carskadon, A. Kapoor, A. Tewari, A. Chandra, N. Palanisamy, B. Ateeq

This study identifies DKC1 as a key regulator in colorectal cancer progression through WNT signaling, showing its role in sphingolipid biosynthesis and proposing ceramides as potential biomarkers.

bioRxiv · Jul 18, 2023 · PreprintCancer Biology

Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer.

A. Yadav, T. Biswas, A. Praveen, P. Ganguly, A. Verma, D. Datta, B. Ateeq

This paper shows that inhibiting MALAT1 increases sensitivity to PARP inhibitors in prostate cancer by impairing homologous recombination.

bioRxiv · Jun 1, 2022 · PreprintCancer Biology

Nuclear biocondensate-forming lncRNA and cellular stress surveillance shape host cancer susceptibility

A. Bajpai, Q. T. Ahmad, S. Kundu, R. K. Pandey, A. G. Goodman, A. Goel, B. Ateeq, S. C. Lakhotia, P. Sinha

This study identifies hsr{omega} and its human homologs as key regulators of cancer susceptibility through stress response pathways in Drosophila and humans.

bioRxiv · Apr 26, 2021 · PreprintCancer Biology

Transcriptional network involving ERG and AR orchestrates Distal-Less Homeobox 1 mediated prostate cancer progression.

S. Goel, V. Bhatia, S. Carskadon, N. Gupta, M. Asim, N. Palanisamy, B. Ateeq

The paper identifies a transcriptional network involving ERG, AR, and DLX1 in prostate cancer progression and shows BET inhibitors can target this network.

bioRxiv · Aug 28, 2020Cancer Biology

A Drosophila model of oral peptide therapeutics for adult intestinal stem cell tumors

A. Bajpai, Q. T. Ahmad, H.-W. Hong-Wen Tang, N. Manzar, V. Singh, A. Thakur, B. Ateeq, N. Perrimon, P. Sinha

This paper evaluates the efficacy of a TONDU peptide in suppressing Yki-driven intestinal stem cell tumors in Drosophila by inhibiting YAP-TEAD interaction and modulating integrin signaling.

bioRxiv · Jan 21, 2020Cancer Biology

Targeting AGTR1/NF-κB /CXCR4 axis by miR-155 attenuates oncogenesis in Glioblastoma

A. Singh, N. Srivastava, B. Ateeq

This study shows miR-155 targets AGTR1's 3UTR, reduces AGTR1-mediated oncogenic processes, and suppresses tumor growth in GBM models.

bioRxiv · Oct 23, 2019Cancer Biology

Androgen deprivation upregulates SPINK1 expression and potentiates cellular plasticity in prostate cancer

R. Tiwari, N. Manzar, V. Bhatia, A. Yadav, S. Carskadon, N. Gupta, A. Zoubeidi, N. Palanisamy, B. Ateeq

This study shows that androgen deprivation therapy upregulates SPINK1, which enhances cellular plasticity and contributes to poor outcomes in prostate cancer.

bioRxiv · Feb 27, 2019Cancer Biology

Epigenetic silencing of miRNA-338-5p and miRNA-421 drives SPINK1-positive prostate cancer.

V. Bhatia, A. Yadav, R. Tiwari, S. Nigam, S. Goel, S. Carskadon, N. Gupta, A. Goel, N. Palanisamy, B. Ateeq

This study identifies miRNA-338-5p and miRNA-421 as epigenetically silenced in SPINK1-positive prostate cancer, and shows their restoration inhibits oncogenic properties.

bioRxiv · Oct 2, 2018Cancer Biology